Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
Company Information
About this company
Key people
Morgan C. Frank
Chairman of the Board, Chief Executive Officer
James Tyler
Independent Director
Peter Sorensen
Chief Financial Officer
Daniel Coyle
Chief Operating Officer
Timothy Wern
Executive Vice President - Sales, U.S. Wound Business
Iulian Cioanta
Chief Science and Technology Officer
Peter Stegagno
Chief Regulatory Officer
Ian Miller
Lead Independent Director
Gregory Bazar
Independent Director
Jeffrey Blizard
Independent Director
Click to see more
Key facts
- Shares in issue8.58m
- EPICSNWV
- ISINUS80303D3052
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$184.52m
- Employees46
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.